TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
1-Year Return
21.62%
This Quarter Return
+3.47%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$659M
AUM Growth
+$165M
(+33%)
Cap. Flow
+$248M
Cap. Flow
% of AUM
37.58%
Top 10 Holdings %
Top 10 Hldgs %
55.02%
Holding
70
New
19
Increased
18
Reduced
1
Closed
3
Top Buys
| 1 |
Veru
VERU
|
$52.3M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$40.8M |
| 3 |
Tarsus Pharmaceuticals
TARS
|
$26.1M |
| 4 |
BLUE
bluebird bio
BLUE
|
$18.1M |
| 5 |
BioCryst Pharmaceuticals
BCRX
|
$12.7M |
Top Sells
Sector Composition
| 1 | Healthcare | 96.15% |
| 2 | Consumer Discretionary | 3.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Enanta Pharmaceuticals
ENTA
$183M
| $6.51M | 0.99% |
137,700
+37,700
| +38% | +$1.78M |
|
27
BioNTech
BNTX
$24.3B
| $5.96M | 0.91% |
40,000
| – | – |
|
28
Kiniksa Pharmaceuticals
KNSA
$2.62B
| $5.81M | 0.88% |
600,000
+100,000
| +20% | +$969K |
|
29
Alibaba
BABA
$313B
| $5.68M | 0.86% |
+50,000
| New | +$5.68M |
|
|
BLU
30
DELISTED
BELLUS Health Inc.
BLU
| $5.54M | 0.84% |
600,000
| – | – |
|
31
Coherus Oncology, Inc. Common Stock
CHRS
$153M
| $5.43M | 0.82% |
750,000
| – | – |
|
32
Arcus Biosciences
RCUS
$1.21B
| $5.07M | 0.77% |
200,000
| – | – |
|
33
Viridian Therapeutics
VRDN
$1.54B
| $4.63M | 0.7% |
+400,000
| New | +$4.63M |
|
34
Nkarta
NKTX
$145M
| $4.31M | 0.65% |
350,000
+150,000
| +75% | +$1.85M |
|
|
ALLK
35
DELISTED
Allakos
ALLK
| $4.14M | 0.63% |
1,323,393
| – | – |
|
|
GNFT
36
Genfit
GNFT
$198M
| $4.06M | 0.62% |
1,261,442
+90,081
| +8% | +$290K |
|
|
TSVT
37
DELISTED
2seventy bio
TSVT
| $3.96M | 0.6% |
300,000
| – | – |
|
38
Pyxis Oncology
PYXS
$96.1M
| $3.28M | 0.5% |
+1,379,080
| New | +$3.28M |
|
39
Corvus Pharmaceuticals
CRVS
$425M
| $3.27M | 0.5% |
3,301,709
+200,000
| +6% | +$198K |
|
|
ATYR
40
aTyr Pharma
ATYR
$521M
| $3.15M | 0.48% |
1,113,453
| – | – |
|
|
DCFC
41
DELISTED
Tritium DCFC Limited Ordinary Shares
DCFC
| $3.05M | 0.46% |
2,500
+1,879
| +303% | +$2.29M |
|
|
LENZ
42
LENZ Therapeutics
LENZ
$1.12B
| $3.03M | 0.46% |
+157,143
| New | +$3.03M |
|
43
ANI Pharmaceuticals
ANIP
$2.07B
| $2.97M | 0.45% |
100,000
| – | – |
|
44
Fortress Biotech
FBIO
$87.5M
| $2.81M | 0.43% |
222,853
+66,186
| +42% | +$834K |
|
45
Vanda Pharmaceuticals
VNDA
$272M
| $2.8M | 0.42% |
256,696
| – | – |
|
46
Legend Biotech
LEGN
$6.43B
| $2.75M | 0.42% |
50,000
| – | – |
|
|
ASLN
47
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
| $2.75M | 0.42% |
138,873
+56,720
| +69% | +$1.12M |
|
48
TScan Therapeutics
TCRX
$103M
| $2.35M | 0.36% |
747,800
+547,800
| +274% | +$1.72M |
|
49
Tango Therapeutics
TNGX
$727M
| $2.12M | 0.32% |
468,750
| – | – |
|
50
Mirum Pharmaceuticals
MIRM
$3.71B
| $1.95M | 0.3% |
+100,000
| New | +$1.95M |
|